Navigation Links
Omnicare, Inc. Agreed to a $124 Million Settlement to Resolve Whistleblower Claims Concerning an Alleged Swapping Scam Involving Below Cost Discounts and Medicare and Me
Date:7/18/2014

Port Washington, NY (PRWEB) July 18, 2014

Parker Waichman LLP, a national law firm that has long been dedicated to protecting the rights of victims who have been defrauded due to unethical behaviors, reports that at least one of two whistleblower cases that were brought over allegations of swapping schemes have been settled for what is believed to be the largest settlement over these types of cases, to date. The cases involved are United States ex rel. Gale v. Omnicare, Inc., 1:10-cv-00127-JG, U.S. District Court, Northern District of Ohio, (Cleveland), filed on October 24, 2013 and United States ex rel. Silver v. Omnicare, Inc., et al., Case No. 1:11-cv-01326-NLH, filed September 19, 2013, in the United States District Court, District Of New Jersey.

According to a release issued by the Department of Justice, Office of Public Affairs on June 25, 2014, the alleged scheme involved nursing homes that were also Medicare and Medicaid participating providers. Under the scheme, the facilities filed reimbursement claims for short-term rehabilitation treatment received by patients for Medicare. Concurrently, Omnicare submitted additional claims to Medicare and Medicaid for the drugs it provided. A former Omnicare pharmacy manager brought the whistleblower case in 2010.

The settlement resolves allegations brought in the lawsuits filed by whistleblowers under the qui tam provisions of the False Claims Act over federal claims concerning per diem contracts, according to the Department of Justice. The state per diem claims are being handled in a whistleblower lawsuit pending in the United State District Court, District of New Jersey (United States ex rel. Silver v. Omnicare, Inc., et al., Case No. 1:11-cv-01326-NLH, filed September 19, 2013). This lawsuit also alleges that Omnicare was involved in other kickbacks related to fee-for-service contracts.

This whistleblower lawsuit, once settled, will provide the whistleblower, former Omnicare pharmacist Donald Gale, with more than $17 million. The states, which jointly funded the Medicare and Medicaid programs impacted by the alleged Omnicare misconduct will receive $8.24 million of the settlement. The federal government will receive the remainder. (United States ex rel. Gale v. Omnicare, Inc., 1:10-cv-00127-JG, U.S. District Court, Northern District of Ohio, (Cleveland), filed on October 24, 2013)

Whistleblowers are crucial to stopping illegal employer activities that may harm citizens and which may also defraud the government and other entities. What many may not realize is that, under certain circumstances, whistleblowers may also maintain their anonymity during much of the whistleblower process, notes Parker Waichman LLP.

The False Claims Act enables private persons to file lawsuits that may provide the government with details that concern such wrongdoings. Under the statute, if it is established that a person knowingly submitted and/or caused others to submit false or fraudulent claims to the United States, the U.S. government may then recover treble damages, Parker Waichman LLP also pointed out. Additional monies may also be received for every statute that has been violated. Should the government successfully resolve or litigate its claims, the whistleblower who initiated the action may also receive a significant portion of the recovered amount.

According to the Justice Department, the Anti-Kickback Statute prohibits offering, paying, soliciting, or receiving compensation to persuade referrals of items or Medicare- and Medicaid-covered, and other federally funded, programs. The Anti-Kickback Statute is meant to ensure that the selection of health care providers and suppliers is not impacted by inappropriate financial incentives and is, rather, based on the patient’s best interests.

Parker Waichman LLP offers free legal consultations to victims of injuries allegedly caused by medical devices and also offers free legal consultations to potential whistleblowers. If you believe that your company is involved in illegal activities, please visit the Whistleblower page at YourLawyer.com or call 1-800-LAW-INFO (1-800-529-4636).

Read the full story at http://www.prweb.com/releases/2014/07/prweb12029818.htm.


'/>"/>
Source: PRWeb
Copyright©2014 Vocus, Inc.
All rights reserved

Related medicine news :

1. $4 Billion DePuy ASR Hip Recall Lawsuit Settlement Reportedly Agreed to by Johnson & Johnson Reports Wright & Schulte LLC
2. NIH awards $20 million over 5 years to train next generation of global health researchers
3. Scientist awarded $1 million grant to develop tools for hepatitis C treatment discovery
4. David H. Koch donates $10 million to Mount Sinais Jaffe Food Allergy Institute
5. $9 million grant awarded to UH to study, treat learning disabilities
6. New report shows 15 million babies born too soon every year
7. Southeast program to fight diabetes awarded nearly $10 million by HHS
8. OHSU study: Misdiagnosis of MS is costing health system millions per year
9. Enzyme corrects more than 1 million faults in DNA replication
10. 53 million Americans might have diabetes by 2025, according to a new study in Population Health Management
11. Asthma Cases Continue to Rise in U.S., Affecting Millions
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2016)... ... December 03, 2016 , ... The Lymphoma Research Foundation (LRF) ... and serving the lymphoma community through a comprehensive series of education programs, outreach ... in New York City, with long-time partners The Paul Foundation, on November 10, ...
(Date:12/4/2016)... ... 04, 2016 , ... "Pro3rd Displace is a set of ... displacement design elements," said Christina Austin - CEO of Pixel Film Studios. ... of design styles that include both left aligned and right aligned options for ...
(Date:12/2/2016)... ... ... Lori G. Cohen and Sara K. Thompson , shareholders in global ... Institute’s 21st Drug & Medical Device Litigation Conference , taking place in New York ... who chairs the firm’s Pharmaceutical, Medical Device & Health Care Litigation Practice and the ...
(Date:12/2/2016)... ... 02, 2016 , ... Advanced Inc., a leading provider of travel therapy and ... to serve as Advanced Inc.’s Chief Financial Officer, effective December 1, 2016. Jason previously ... financial and operational leadership experience to Advanced Inc. He began his career in finance ...
(Date:12/2/2016)... ... December 02, 2016 , ... With the number of pain management programs ... patients must find the one that works for them. When an inventor from Suisun ... that worked and decided to share it with others. , He developed a prototype ...
Breaking Medicine News(10 mins):
(Date:12/4/2016)... N.J. , Dec. 3, 2016  Findings ... and safety of CTL019, an investigational chimeric antigen ... (r/r) pediatric and young adult patients with B-cell ... during an oral session at the 58th American ... December 3, 4:00-5:30 p.m.). The global Phase II ...
(Date:12/2/2016)... bioLytical Laboratories, un líder mundial en test rápidos de ... Self Test , a los miembros de la Kenya Pharmaceutical Association. ... ... INSTI HIV Self Test! (PRNewsFoto/bioLytical Laboratories) ... (Photo: http://photos.prnewswire.com/prnh/20161201/444905 ) bioLytical fue invitada por la Clinton ...
(Date:12/2/2016)... According to the latest market report ... Automated Endoscope Reprocessors: Single Basin Automated Endoscope Reprocessors Product Type ... and 2024 " the global automated endoscope reprocessors market was valued at US$ ... a CAGR of 7.2% during an eight-year forecast period 2016-2024, ... 2024. ...
Breaking Medicine Technology: